Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - Norway
Summary - Monitoring Of The Medicines Adalimumab And Infliximab, Tests For Concentration In Serum To St. Olav Hospital H
Deadline - Jan 16, 2025
GT reference number - 99112819
Product classification - Laboratory reagents
Address - Norway
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 99112819
Document Type - Tender Notices
Description - Description: The Department of Immunology and Transfusion Medicine at St.Olavs Hospital uses the above mentioned tests to measure the concentration of the medicines in human serum in patients with autoimmune encephalosis diseases (such as arthritis, Crohn's disease, ulcerative colitis, colorus and multiple sclerosis (MS)). The analyses are part of the disease follow-up, where a monitors medicine concentration.local title:: Monitoring of the medicines Adalimumab and Infliximab, tests for concentration in serum to St. Olav Hospital HContract Duration: : 120 MONTHContract Type: : Supplylocal description: : The Department of Immunology and Transfusion Medicine at St.Olavs Hospital uses the above
Gt Ref Id - 99112819
Deadline - Jan 16, 2025
Similar Tenders :
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database